Le Lézard
Classified in: Health
Subjects: LGB, MAT, DEI

Celebrating LGBTQ+ Sexual Health and Wellbeing


TORONTO, June 23, 2022 /CNW/ - SIECCAN and Trojan asked 1,500 18- to 24-year-old students attending universities in Canada about their sexual health and well-being.  26% identified as LGBTQ+ and reported on their sexual health and wellbeing:  http://sieccan.org/wp-content/uploads/2022/06/SIECCAN-TROJAN-PRIDE2022.pdf

To learn more about SIECCAN please visit sieccan.org.  For more information on TROJANtm, please visit trojan.ca.

About SIECCAN
The Sex Information and Education Council of Canada (SIECCAN) is a not-for-profit charitable organization that works with health professionals, educators, community organizations, governments, and other partners to promote the sexual and reproductive health of Canadians.

About TROJANtm
TROJANtm is Canada's #1 Sexual Wellness brand. Trusted for over 100 years. TROJANtm offers a wide range of premium quality Condoms, Personal Lubricants and Vibrators. TROJANtm latex condoms are made from premium quality latex to help reduce the risk of unintended pregnancy and sexually transmitted infections. Every condom is electronically tested to help ensure reliability. TROJANtm Lubricants offer a wide selection of water-based and silicone-based lubricants that can help enhance intimacy and pleasure. TROJANtm Vibrations is a line of high-quality vibrators and rings, offering unique features including multiple speeds, pulse patterns and a variety of sizes and sensual designs. TROJANtm is committed to investing in public health efforts to support sexual health. For more information, visit www.Trojan.ca.

SOURCE TROJANtm


These press releases may also interest you

at 06:15
The Barbara Ann Karmanos Cancer Institute welcomes Wasif Saif, M.D., MBBS, as the new leader of the Phase 1 Clinical Trials Multidisciplinary Team and co-leader of the Gastrointestinal (GI) and Neuroendocrine Oncology Multidisciplinary Team...

at 06:07
Seed Health will present new clinical data on its flagship innovation, DS-01® Daily Synbiotic, a 24-strain probiotic and prebiotic, at the upcoming 2024 Digestive Disease Week® (DDW) meeting. The presentations will highlight the results from two...

at 06:05
Arrowhead Pharmaceuticals, Inc. today announced that new interim clinical data on ARO-RAGE, an investigational RNAi-based medicine for the treatment of inflammatory lung diseases, such as asthma, were presented at the American Thoracic Society (ATS)...

at 06:00
BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapeutics for neurodegenerative diseases, will present new biomarker data suggesting that ALS patients may benefit from longer-term treatment with debamestrocel...

at 06:00
Ibex Medical Analytics (Ibex), a global leader in AI-powered cancer diagnostics, and Kameda Medical Center (Kameda), a leading Japanese institute at the pinnacle of healthcare innovation, today announced the publication of a clinical study evaluating...

at 06:00
HaemaLogiX Ltd, a clinical stage biotech developing novel immunotherapies for patients with blood cancers and B-cell diseases, is pleased to announce the appointment of Professor the Hon Greg Hunt, former Australian Federal Minister for Health, to...



News published on and distributed by: